DAFTAR PUSTAKA

Adham, M. et al., 2012. Nasopharyngeal carcinoma in

indonesia: Epidemiology, incidence, signs, and
symptoms at presentation. Chinese Journal of
Cancer, 31, pp.185196.
Allen Chan, K.C. & Dennis Lo, Y.M., 2002.
Circulating EBV DNA as a tumor marker for
nasopharyngeal carcinoma. In Seminars in Cancer
Biology. pp. 489496.
Balfour, H.H. et al., 2013. Age-specific prevalence
of Epstein-Barr virus infection among individuals
aged 6-19 years in the United States and factors
affecting its acquisition. The Journal of
infectious diseases, 208(8), pp.128693.
http://www.ncbi.nlm.nih.gov/pubmed/23868878
[Accessed January 2, 2015].
Brink, A.A.T.P. et al., 1998. Nucleic acid sequence-
based amplification, a new method for analysis of
spliced and unspliced Epstein-Barr virus latent
transcripts, and its comparison with reverse
transcriptase PCR. Journal of Clinical
Microbiology, 36, pp.31643169.
Brooks, L. et al., 1992. Epstein-Barr virus latent
gene transcription in nasopharyngeal carcinoma
cells: coexpression of EBNA1, LMP1, and LMP2
transcripts. Journal of virology, 66, pp.2689
2697.
Conway, D.I. et al., 2010. Components of
socioeconomic risk associated with head and neck
cancer: A population-based case-control study in

58
 Scotland. British Journal of Oral and Maxillofacial
Surgery, 48, pp.1117.
Crawford, D.H. et al., 2006. A Cohort Study among
University Students: Identification of Risk Factors
for Epstein-Barr Virus Seroconversion and
Infectious Mononucleosis. Clinical Infectious
Diseases, 43, pp.276282.
Deng, H. et al., 1995. Serological survey of
nasopharyngeal carcinoma in 21 cities of south
China. Chinese Medical Journal, 108, pp.300303.
Dowd, J.B. et al., 2013. Seroprevalence of Epstein-
Barr Virus Infection in U.S. Children Ages 6-19,
2003-2010. PLoS ONE, 8.
Ekburanawat, W. et al., 2010. Evaluation of non-
viral risk factors for nasopharyngeal carcinoma in
Thailand: Results from a case-control study. Asian
Pacific Journal of Cancer Prevention, 11, pp.929
932.
Evans, A.S. 1972. Clinical syndromes associated with
EB virus infection. Adv Intern Med 18:77-93.
Fachiroh, J. et al., 2004. Molecular diversity of
Epstein-Barr virus IgG and IgA antibody responses
in nasopharyngeal carcinoma: a comparison of
Indonesian, Chinese, and European subjects. The
Journal of infectious diseases, 190, pp.5362.
Fachiroh, J., et al. 2006. Single-Assay Combination
of Epstein-Barr Virus (EBV) EBNA1 and Viral Capsid
Antigen-p18-Derived Syntetic Peptides for
Measuring anti-EBV Immunoglobulin G (IgG) and IgA
Antibody Levels in Sera from Nasopharyngeal

59
 Carcinoma Patients: Option for Fields Screening,
44, 145967.
Ferlay J., et al. 2010. GLOBOCAN 2008 v2.0, Cancer
Incidence and Mortality Worldwide: IARC
CancerBase. No. 10 [Internet]. Lyon, France:
International Agency for Research on Cancer; 2010.
Available from: http://globocan.iarc.fr, accessed
on 9/12/2013.
Foong, Y.T. et al., 1990. Serum and salivary IgA
antibodies against a defined epitope of the
Epstein-Barr virus nuclear antigen (EBNA) are
elevated in nasopharyngeal carcinoma.
International Journal of Cancer, 45, pp.10611064.
Gulley, M. 2001. Review: molecular diagnosis of
Epstein-Barr virus-related diseases. J. Mol.
Diagnostics 1:110.
Harijadi, Haryanto A, Wijayanti N. Tipe Epstein-Barr
Virus Berdasarkan Analisis Molekuler Gena EBNA
Pada Penderita Nasopharyngeal Di Yogyakarta.
Berita Ked Masyarakat 2000; 16 (1) : 3-8.
Henle, G. & Henle, W., 1976. Epstein-Barr virus-
specific IgA serum antibodies as an outstanding
feature of nasopharyngeal carcinoma. International
journal of cancer. Journal international du
cancer, 17(1), pp.17.
Hutajulu, S.H. et al., 2011. Epstein-Barr Virus
(EBV) Serological Screening Combined with EBV DNA
Load in Nasopharyngeal Brushings for
Identification of Nasopharyngeal Carcinoma in
Individual with Chronic Complaints in Head and
Neck. International Journal of Cancer.

60
Ji, M.F. et al., 2007. Sustained elevation of
Epstein-Barr virus antibody levels preceding
clinical onset of nasopharyngeal carcinoma.
British journal of cancer, 96, pp.623630.
Kurniawan, A., R. Kodariah, M. Elisabeth, A. Roezin,
and S. Gondhowihardjo. 2002. Evaluation of EBV-
LMP1 as prognostic indicator of nasopharyngeal
carcinoma. Medical Indonesian Journal 11:81-86.
Lee, A.W.M. et al., 2005. Treatment results for
nasopharyngeal carcinoma in the modern era: The
Hong Kong experience. International Journal of
Radiation Oncology Biology Physics, 61, pp.1107
1116.
Lin, J.C. et al., 2003. Phase III study of
concurrent chemoradiotherapy versus radiotherapy
alone for advanced nasopharyngeal carcinoma:
positive effect on overall and progression-free
survival. J Clin Oncol, 21, pp.6317.
Ozyar, E. et al., 2004. Prognostic role of Ebstein-
Barr virus latent membrane protein-1 and
interleukin-10 expression in patients with
nasopharyngeal carcinoma. Cancer investigation,
22, pp.483491.
Neel, H.B. & Taylor, W.F., 1990. Epstein-Barr virus-
related antibody. Changes in titers after therapy
for nasopharyngeal carcinoma. Archives of
otolaryngology--head & neck surgery, 116, pp.1287
1290.
Ng, M.H. et al., 2006. Epstein-Barr virus serology
in early detection and screening of nasopharyngeal
carcinoma. Chinese journal of cancer. 25: 2506.

61
Paramita, D.K. et al., 2009. Two-step Epstein-Barr
virus immunoglobulin A enzyme-linked immunosorbent
assay system for serological screening and
confirmation of nasopharyngeal carcinoma. Clinical
and vaccine immunology: CVI, 16(5), pp.706711.
Pearson G. R., Taylor W. F., Mulroney S., Weilad L.
H and Neel H.B, 1983. Clinical Immunovirology
Current Status. In Nasopharyngeal Carcinoma,
Current Concepts eds Prasad U., Ablashi D. V.,
Levine P. H and Pearson G. R. University of
Malaysia Kuala Lumpur. hal 87-97.
Perez-Ordonez, B. An update on Epstein-Barr virus
and nasopharyngeal carcinogenesis. Head Neck
Pathol 2007, 1:141145
Prathap K., Prasad U and Ablashi D. V, 1983. The
Pathology of Nasopharyngeal Carcinoma in Malaysian
IN Nasopharyngeal Carcinoma Current Concepts. eds.
Prasad U., Ablashi D. V, Levine P. H and Pearson
G. R. University of Malaysia Kuala Lumpur. hal 55-
63.
Purba, Indrayani, 1997. Penegakan Diagnosis
Imunologik Karsinoma Nasofaring dengan Pemeriksaan
IgA Anti VCA-EBV Metode IPA. Fakultas Kedokteran
Universitas Gadjah Mada. Yogyakarta.
Rickinson, A. B., and E. Kieff. 2006. Epstein-Barr
Virus, p. 2655-2700. In D. Knipe and P. Howley
(ed.), Fields Virology, 5th ed. Lippincott Williams
& Wilkins, Philadelphia.
Roezin A. Berbagai Faktor Penyebab dan Predisposisi
Karsinoma Nasofaring. Maj Ked Ind, 1999;49 (3):
85-88.

62
Schuster, C., Chasserot-Golaz, S. & Beck, G., 1991.
Activation of Epstein-Barr virus promoters by a
growth-factor and a glucocorticoid. FEBS Letters,
284, pp.8286.
Sham, J.S. et al., 1990. Detection of subclinical
nasopharyngeal carcinoma by fibreoptic endoscopy
and multiple biopsy. Lancet, 335, pp.371374.
Shanmugaratnam, K. & Sobin, L.H., 1993. The World
Health Organization histological classification of
tumours of the upper respiratory tract and ear. A
commentary on the second edition. Cancer, 71,
pp.26892697.
Soeripto. 1998. Epidemiology of Nasopharyngeal
Carcinoma. Berita Kedokteran Masyarakat XIV: 207-
211.
Soetjipto D., Iskandar H. N., Munir H.M, 1989.
Karsinoma Nasofaring dalam Tumor Telinga Hidung
Diagnosis dan Penatalaksanaan. Fakultas Kedokteran
UI Jakarta. hal 71-85.
Wei, W.I., Sham, J.S.T., 2005. Nasopharyngeal
carcinoma. Lancet. pp. 20412054.
Weiland L. H, 1983. Clinical Pathology of
Nasopharyngeal Carcinoma in Current Status In.
Nasopharyngeal Carcinoma Current Concepts eds
Prasad U., Ablashi D. V Levine P. H and Pearson G.
R. University of Malaysia Kuala Lumpur. hal 35-39.
Yu M.C. dan Henderson B.E. Nasopharyngeal cancer.
In: D. Schottenfeld and J. Fraumeni (eds.), Cancer
epidemiology and prevention, pp. 603-618, Oxford
University Press, New York (1996).

63
Yuan J.M., Wang X.L., Xiang Y.B., Gao Y.T., Ross
R.K., Yu M.C. Non-dietary risk factors for
nasopharyngeal carcinoma in Shanghai, China. Int J
Cancer 2000;85:364-9.
Yuan, J.M. et al., 2000. Non-dietary risk factors
for nasopharyngeal carcinoma in Shanghai, China.
International Journal of Cancer, 85, pp.364369.
Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY,
Wang YB, Jiang MK, Fang Z, Meng NN (1985)
Prospective studies on nasopharyngeal carcinoma in
Epstein-Barr virus IgA/VCA antibody- positive
persons in Wuzhou City, China. Int J Cancer 36
(5):545-547
Zou J, Sun Q, Akiba S, Yuan Y, Zha Y, Tao Z, Wei L,
Sugahara T. A case control study of
nasopharyngeal carcinoma in the high background
radiation areas of Yangjiang, China. J Radiat Res
(Tokyo) 2000;41 Suppl:53-62.

64